Who invested in Trace Genomics

3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AgtechBiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$28Mraised across 3 rounds since 2016, from 3 sources

$4.0MRound$13MSeries A$11MSeries B

Latest round: Series B, $11MFeb 2024
Biggest round: $13MSeries A · Nov 2018
Investors: 6 (1 led)

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2018202020222024

$4.0MRound$13MSeries A$11MSeries B

First round: Round, $4.0M
Biggest round: $13M
Usual gap between rounds: 5.3 years

The rounds

Feb 2024
Series B$11M4 new1 returning
Source recorded
Nov 2018
Series A$13M1 new
- Stage 1 Ventures
Reported by ForbesSEC filing: $20M sold, first sale May 2018
Jul 2016
Round$4.0M1 new
- Refactor CapitalLead
Reported by TechCrunch

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2016Series A2018Series B2024

Everyone who backed them

Refactor CapitalVC firm2rounds, led 1

SVG VenturesAccelerator1round

S2G InvestmentsGrowth equity1round

AgFunderVC firm1round

Viking GlobalVC firm1round

Stage 1 VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Trace Genomics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.